IGF-I and IGF-II expression in human breast cancer xenografts: Relationship to hormone independence (original) (raw)

References

  1. Dickson RB, Lippman ME: Estrogen regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Reviews 8:29–43, 1986.
    Google Scholar
  2. Brünner N, Zugmaier G, Bano M, Ennis BW, Clarke R, Cullen KJ, Kern FG, Dickson RB, Lippman ME: Endocrine therapy of human breast cancer cells: The role of secreted polypeptide growth factors. Cancer Cells 1:81–86, 1989.
    PubMed Google Scholar
  3. Bates SE, Davidson NE, Valverius EM, Dickson RB, Freter CE, Tam JP, Kudlow JE, Lippman ME, Salomon DS: Expression of transforming growth factor alpha and its mRNA in human breast cancer: Its regulation by estrogen and its possible functional significance. Mol Endocrinol 2:543–555, 1988.
    PubMed Google Scholar
  4. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB: Evidence that transforming growth factor beta is a hormonally regulated negative growth factor in human breast cancer cells. Cells 48:417–428, 1987.
    Google Scholar
  5. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N: Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48:6691–6696, 1988.
    PubMed Google Scholar
  6. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N: Analysis of IGF-I gene expression in malignancy — evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509–517, 1989.
    PubMed Google Scholar
  7. Myal Y, Shiu RPC, Bhaumick B, Bala M: Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T47D) in culture. Cancer Res 44:5486–5490, 1984.
    PubMed Google Scholar
  8. Tobin G, Yee D, Brünner N, Rotwein P: A novel human insulin-like growth factor I messenger RNA is expressed in normal and tumor cells. Mol Endocrinol 4:1914–1920, 1990.
    PubMed Google Scholar
  9. Brünner N, Yee D, Kern FG, Spang-Thomsen M, Lippman ME, Cullen KJ: Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II). Cancer Res (submitted).
  10. Rohlik QT, Adams D, Kull FC, Jacobs S: An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun 149:276–281, 1987.
    PubMed Google Scholar
  11. Arteaga CL, Kitten L, Coronado E, Jacobs S, Kull F, Allred DC, Osborne CK: Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418–1423, 1989.
    PubMed Google Scholar
  12. Brünner N, Osborne CK, Spang-Thomsen M: A review: Endocrine therapy of human breast carcinomas grown in nude mice. Breast Cancer Res Treat 10:229–242, 1987.
    PubMed Google Scholar
  13. Brünner N, Svenstrup B, Spang-Thomsen M, Bennett P, Nielsen A, Nielsen J: Serum steroid levels in intact and endocrine ablated BALB/c nude mice and their intact littermates. J Steroid Biochem 25:429–432, 1986.
    PubMed Google Scholar
  14. DeLeon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG: Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Commun 152:398–405, 1988.
    PubMed Google Scholar
  15. Cullen KJ, Yee D, Sly WS, Perdue JF, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48–53, 1990.
    PubMed Google Scholar
  16. Peyrat JP, Bonneterre J, Beuscart R, Djiane J, Demaille A: Insulin-like growth factor I receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 48:6429–6433, 1988.
    PubMed Google Scholar
  17. Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC, Allred DC, Osborne CK: Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418–1423, 1989.
    PubMed Google Scholar
  18. Brown AMC, Jeltsch J-M, Roberts M, Chambon P: Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81:6344–6348, 1984.
    PubMed Google Scholar
  19. Clarke R, Brünner N, Katzenellenbogen BS, Thompson EW, Norman MJ, Koppi C, Paik S, Dickson R, Lippman ME: Progression of human breast cancer cells from hormone dependent to hormone independent growth both in vitro and in vivo. Proc Natl Acad Sci USA 86:3649–3653, 1989.
    PubMed Google Scholar
  20. Brünner N, Boulay V, Fojo A, Freter CE, Lippman ME, Clarke R: Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of specific estrogen-regulated genes but without detectable DNA amplifications. Cancer Res (submitted).
  21. Daly RJ, King RJ, Darbre PD: Interaction of growth factors during progression towards steroid independence in T-47-D human breast cancer cells. J Cell Biochem 43:199–211, 1990.
    PubMed Google Scholar
  22. Gansler T, Furlanetto R, Gramling TS, Robinson KA, Blocker N, Buse MG, Sens DA, Garvin AJ: Antibody to type I insulin-like growth factor receptor inhibits growth of Wilm's tumor in culture and in athymic nude mice. Am J Pathol 135:961–966, 1989.
    PubMed Google Scholar

Download references